Trial
NCT06708611
A Crossover Study of Patients With HF to Compare Natriuretic Effects of IR Torsemide vs. ER Torsemide Over 12 Hrs
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sarfez Pharmaceuticals, Inc.
Collaborators
—
Condition
Heart Failure
Intervention
torsemide
Why stopped
Recruitment issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-27